IP Library Granted Patent US 7,332,338
Granted Patent B2
US 7,332,338 · App. 10/917,273 · Granted Feb 19, 2008

Vectors for making genomic modifications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,332,338
App. No.
10/917,273
Granted
Feb 19, 2008
Kind
B2
Abstract

Methods and vectors (both DNA and retroviral) are provided for the construction of a Library of mutated cells. The Library will preferably contain mutations in essentially all genes present in the genome of the cells. The nature of the Library and the vectors allow for methods of screening for mutations in specific genes, and for gathering nucleotide sequence data from each mutated gene to provide a database of tagged gene sequences. Such a database provides a means to access the individual mutant cell clones contained in the Library. The invention includes the described Library, methods of making the same, and vectors used to construct the Library. Methods are also provided for accessing individual parts of the Library either by sequence or by pooling and screening. The invention also provides for the generation of non-human transgenic animals which are mutant for specific genes as isolated and generated from the cells of the Library.

Claims (13)

1. A retroviral vector for replacing the 3′ end of an animal cell transcript with a foreign exon, comprising:

a) a foreign exon;

b) a splice acceptor operatively positioned 5′ to said foreign exon;

c) a polyadenylation site operatively positioned 3′ to said foreign exon;

d) a first site-specific recombinase site upstream of the splice acceptor; and

e) a second site-specific recombinase site downstream of the splice acceptor;

wherein said vector does not comprise a promoter element operatively positioned relative to the foreign exon.

2. The vector of claim 1 , wherein the second recombinase site is downstream of the polyadenylation site.

3. The vector of claim 1 , wherein the first and second recombinase sites are selected from loxP and frt.

4. The vector of claim 1 , wherein the foreign exon is a selectable marker.

5. A method of producing a collection of mutated animal cells, comprising

exposing a group of animal cells in vitro to the vector of claim 1 under conditions allowing stable integration of the vector into an animal cell genome; and

selecting cells that express the product encoded by the foreign exon.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
CHANGE OF NAME Recorded Aug 6, 2007
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 019649/0559 →